← SynDRA
VELIPARIB
SynDRA canonical compound SYN0016413 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PARP1 |
|---|
| Mechanism of action | PARP inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PARP inhibitor
- PARP1 INHIBITOR
- PARP 1, 2 and 3 inhibitor
- PARP3 INHIBITOR
- PARP2 INHIBITOR
Drug classes
- Poly(ADP-ribose) Polymerase Inhibitors
ATC classes
- L01X · OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- ABT-888
- ABT-888 (VELIPARIB)
- ABT888
- NSC 737664
- PARP-1 INHIBITOR ABT-888
- UNII-01O4K0631N
- VELIPARIB (ABT-888)
- ABT 888
- ABT-888 (Veliparib)
- Veliparib (ABT-888)
- 2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide
- CHEBI:62880
- 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide
- (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-4-carboxamide
- 01O4K0631N
- 2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benimidazole-4-
- (2r)-2-(7-Carbamoyl-1h-Benzimidazol-2-Yl)-2-Methylpyrrolidinium
- Veliparib dihydrochloride
- NSC737664
- veliparibum
- RefChem:901780
- DTXCID10160947
- Veliparib free base
- MFCD16661059
- NSC-737664
- Veliparib (ABT-888 hydrochloride)
- Veliparib [USAN:INN]
- Veliparib, Free Base
- VELIPARIB [INN]
- VELIPARIB [JAN]
- VELIPARIB [USAN]
- ABT888 (free base)?
- VELIPARIB [WHO-DD]
- A861695
- benzimidazole carboxamide, 3a
- MLS006010184
- Veliparib (JAN/USAN/INN)
- SCHEMBL422318
Look up VELIPARIB in the interactive SynDRA portal →